000 | 01624 a2200469 4500 | ||
---|---|---|---|
005 | 20250513063451.0 | ||
264 | 0 | _c19940601 | |
008 | 199406s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRingdén, O | |
245 | 0 | 0 |
_aA randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. _h[electronic resource] |
260 |
_bBlood _cMay 1994 |
||
300 |
_a2723-30 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 |
_aBusulfan _xadverse effects |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCystitis _xepidemiology |
650 | 0 | 4 |
_aCytomegalovirus Infections _xepidemiology |
650 | 0 | 4 |
_aGraft vs Host Disease _xepidemiology |
650 | 0 | 4 |
_aHepatic Veno-Occlusive Disease _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xtherapy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aWhole-Body Irradiation _xadverse effects |
700 | 1 | _aRuutu, T | |
700 | 1 | _aRemberger, M | |
700 | 1 | _aNikoskelainen, J | |
700 | 1 | _aVolin, L | |
700 | 1 | _aVindeløv, L | |
700 | 1 | _aParkkali, T | |
700 | 1 | _aLenhoff, S | |
700 | 1 | _aSallerfors, B | |
700 | 1 | _aLjungman, P | |
773 | 0 |
_tBlood _gvol. 83 _gno. 9 _gp. 2723-30 |
|
999 |
_c8166669 _d8166669 |